Replies to post #402784 on Amarin Corp Plc (AMRN)

[Mr Stockboy]

I totally agree with you. Amarin is already driving all its revenue out of the USA. Why on earth would a BOD chairman say we've given up...we're abandoning it? It totally makes no sense as any company like Pfizer in Canada can combo Vascepa with its own CVD portfolio (one example). This has actually angered me. If Amarin works in the USA to increase volume they still win. They seem TOTALLY BLIND. Plus as you mentioned the other indications. Great post on your part!!!

[rosemountbomber]

Absolutely Zip. Plus as many of us know and as Denner pointed out, a BP's sales rep can just add Vascepa to their repertoire without any real cost whereas it would not be at all cost effective for Amarin to do since many of the scripts go to Generics. For BP they basically lose nothing promoting V.